Reiner Frey

Wuppertal, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Anthropometric measurements of the abdominal wall: toward standardization and difficulty grading in rTAPP inguinal.

Anthropometric measurements of the abdominal wall: toward standardization and difficulty grading in rTAPP inguinal.

Journal: Journal of abdominal wall surgery : JAWS
Published: April 15, 2026

Tissue repair: suture closure of the internal inguinal ring in rTAPP.

Tissue repair: suture closure of the internal inguinal ring in rTAPP.

Journal: Hernia : the journal of hernias and abdominal wall surgery
Published: March 24, 2026

Transition phase to robot-assisted surgery for colorectal cancer: a comparative consecutive cohort study

Transition phase to robot-assisted surgery for colorectal cancer: a comparative consecutive cohort study

Journal: Chirurgie (Heidelberg, Germany)
Published: April 14, 2025

Occult hernias, classification of inguinal lipomas and chronic postoperative groin pain

Occult hernias, classification of inguinal lipomas and chronic postoperative groin pain

Journal: Chirurgie (Heidelberg, Germany)
Published: April 09, 2025

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.

Journal: Pulmonary circulation
Published: April 19, 2019

Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.

Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.

Journal: Clinical pharmacokinetics
Published: November 01, 2017

Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Journal: Respiratory medicine
Published: October 25, 2016

Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Journal: Pulmonary circulation
Published: May 11, 2016

Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Journal: Pulmonary circulation
Published: May 11, 2016

Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Journal: Pulmonary circulation
Published: May 11, 2016

Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam.

Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam.

Journal: Pulmonary circulation
Published: May 11, 2016

Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment.

Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment.

Journal: Pulmonary circulation
Published: May 11, 2016
Showing 1-12 of 26

Last Updated: 09/26/2026